Evans, 2011 - Google Patents
Drug discovery and development for ageing: opportunities and challengesEvans, 2011
View HTML- Document ID
- 1496924572901905383
- Author
- Evans W
- Publication year
- Publication venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
External Links
Snippet
The prevention and treatment of late-life dysfunction are the goals of most geriatricians and should be the primary target for discovery and development of new medicines for elderly people. However, the development of new medicines for elderly people will face a number …
- 230000032683 aging 0 title abstract description 30
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3475—Computer-assisted prescription or delivery of diets, e.g. prescription filling or compliance checking
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3418—Telemedicine, e.g. remote diagnosis, remote control of instruments or remote monitoring of patient carried devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
de Souto Barreto et al. | Association of long-term exercise training with risk of falls, fractures, hospitalizations, and mortality in older adults: a systematic review and meta-analysis | |
Bijnen et al. | Physical activity and 10-year mortality from cardiovascular diseases and all causes: the Zutphen Elderly Study | |
Grossman et al. | Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US Preventive Services Task Force recommendation statement | |
Barrett-Connor et al. | Coffee-associated osteoporosis offset by daily milk consumption: the Rancho Bernardo Study | |
Taubert et al. | Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial | |
Leitzmann et al. | A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men | |
Herring et al. | Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials | |
Nordmann et al. | Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials | |
Lloyd et al. | Calcium supplementation and bone mineral density in adolescent girls | |
Harris et al. | Metan: fixed-and random-effects meta-analysis | |
Gage et al. | Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2 | |
Prince et al. | Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women | |
Davidson et al. | Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial | |
Buijsse et al. | Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study | |
Khosla et al. | Incidence of childhood distal forearm fractures over 30 years: a population-based study | |
Vanharanta et al. | Risk of cardiovascular disease–related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study | |
Eng | Sample size estimation: how many individuals should be studied? | |
Kujala et al. | Physical activity and osteoporotic hip fracture risk in men | |
Diem et al. | Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures | |
Joffe et al. | A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression | |
Huang et al. | Vertebral fracture and other predictors of physical impairment and health care utilization | |
Larsson et al. | Tea consumption and ovarian cancer risk in a population-based cohort | |
Scranton et al. | Statin use and fracture risk: study of a US veterans population | |
Williamson et al. | Evidence regarding the benefits of physical exercise | |
Evans | Drug discovery and development for ageing: opportunities and challenges |